Information for Patients portlet

News
Article

English and Spanish PDFs

Breast Cancer Screening Saves LivesLas pruebas de deteccin de cncer de mama salvan vidasTreatment of HER2 Positive Early Breast CancerTratamiento del cncer de mama HER2 positivo en estadio tempranoUnderstanding MammographyGua para entender la mamografa Melanoma: What You Need to Know Melanoma: Cosas que necesita saberInformation for Patients: Understanding ColonoscopyInformacion para los Pacientes: Lo que debe saber sobre la colonoscopia

HER2+ Early Breast Cancer: Understanding Adjuvant Treatment

HER2: Comprenda el tratamiento adyuvante

I Have HER2+ Metastatic Breast Cancer: Is My Treatment Working?

HER2: ¿Est mi tratamiento dando resultados?

HER2: What You Need to Know

HER2: Cosas que necesita saber

Mucositis (Mouth Soreness)

Mucositis (Estomatitis Oral)

Nausea and Vomiting

What You Need to Know About Fever and Neutropenia

Lo Que Debes Saber Sobre la Fiebre y Neutropenia

Constipation in the Cancer Patient

Informacin Para los Pacientes: El Estreimiento en el Paciente con Cncer

Peripheral Neuropathy and Cancer

Informacin Para los Pacientes: La Neuropata Perifrica y el Cncer

Information for Patients: Diarrhea in Cancer Patients

Informacin Para los Pacientes: La Diarrea en Pacientes con Cncer

Information for Patients: Fatigue in People With Cancer

Informacin Para los Pacientes: La Fatiga en Personas con Cncer

Information for Patients: Managing Cancer Pain

Informacin Para los Pacientes: Cmo Manejar el Dolor del Cncer

Information for Patients: Understanding and Managing Nausea and Vomiting Informacin Para los Pacientes: Cmo entender y manejar las nuseas y vmitos

Recent Videos
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
A panel of 5 experts on multiple myeloma
A panel of 5 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma